Yang Fei Tan

Yang Fei Tan

Auto-generated profile, based on publicly available information

Yang Fei Tan

Materials Science and Engineering, National University of Singapore, Singapore 117599, Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2020 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
ADAnastasia Darwitan
Anastasia Darwitan
YTYang Fei Tan
Yang Fei Tan
YWYee Shan Wong
Yee Shan Wong
ANAnu Maashaa Nedumaran
Anu Maashaa Nedumaran
BCBertrand Czarny
Bertrand Czarny
SVSubbu Venkatraman
Subbu Venkatraman
Nanoparticles that actively target tissues, with ligands attached at the extremity of polyethylene glycol (PEG) spacer, are a promising strategy to enhance target cell specificity and internalizati...

10 September 2018 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
YTYang Fei Tan
Yang Fei Tan
YLYing Shi Lee
Ying Shi Lee
LSLi-Fong Seet
Li-Fong Seet
KNKee Woei Ng
Kee Woei Ng
TWTina T Wong
Tina T Wong
SVSubbu Venkatraman
Subbu Venkatraman
Objectives: Clinical translation of siRNA therapeutics has been severely limited due to the lack of stable and sustained siRNA delivery systems. Furthermore, when nanocarrier systems with siRNA are administered systemically to treat diseases, insufficient doses reach the target tissue. Here we report the successful development of a new nanocarrier system for the management of fibrosis. Methods: The new carrier has a hydroxyapatite core, with alternating layers of siRNA and a cationic peptide. The siRNA used here targets secreted protein acidic and rich in cysteine (SPARC), a key matricellular protein involved in the regulation of collagen fibrillogenesis and assembly. We have also used FRET studies to elucidate the fate of the particles inside cells, including the mechanistic details of layer-by-layer detachment. Results: In vitro studies using murine conjunctiva fibroblasts show sustained release over 2 weeks, and that such released siRNA sustained SPARC knockdown without affecting cell growth, and maintained siRNA presence in the cells for at least two weeks with a single-dose treatment. Release studies of siRNA from particles in vitro gave insight on how the particles delivered prolonged gene-silencing effects. Conclusion: A single treatment of the layer-by-layer nanoparticle designed can achieve sustained gene silencing over 2 weeks. Localized delivery of stabilized siRNA with sustained-release capabilities opens the door for many other applications of siRNA-based gene regulation.

1 January 2024 in World Scientific Annual Review of Functional Materials
Verified
Journal Article
Closed access
YTYang Fei Tan
Yang Fei Tan
SVSubbu Venkatraman
Subbu Venkatraman